Table 2.
Prevalence of HLAR among Enterococcus species isolated from clinical specimens based on specimen type
HLAR | ||||||
---|---|---|---|---|---|---|
HLGR | HLSR | |||||
Specimen type | E. faecalis (n = 36) n (%) | E. faecium (n = 18) n (%) | non-faecalis non-faecium (n = 13) n (%) | E. faecalis (n = 33) n (%) | E. faecium (n = 16) n (%) | non-faecalis non-faecium (n = 14) n (%) |
Urine | 31 (86.10) | 15 (83.33) | 11 (84.61) | 27 (81.80) | 12 (75) | 11 (78.60) |
Blood | 4 (11.11) | 3 (16.66) | 2 (15.40) | 5 (15.15) | 4 (25) | 3 (21.43) |
Wound | 1 (2.80) | - | - | 1 (3.00) | - | - |
HLAR; High level aminoglycoside resistance, HLGR; High level gentamicin resistance, HLSR; High level streptomycin resistance